Evidence map›Paper›PMID 20086095›Full record

ArticleMolecular and cellular biology2010

Cross talk between phosphatidylinositol 3-kinase and cyclic AMP (cAMP)-protein kinase a signaling pathways at the level of a protein kinase B/beta-arrestin/cAMP phosphodiesterase 4 complex.

Elisa Bjørgo, Silje A Solheim, Hilde Abrahamsen, George S Baillie, Kim M Brown, Torunn Berge, Klaus Okkenhaug, Miles D Houslay, Kjetil Taskén

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 62 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. The Role of PDE8 in T Cell Recruitment and Function in Inflammation.Frontiers in cell and developmental biology · 2021
    Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Mitochondrial cAMP signaling.Cellular and molecular life sciences : CMLS · 2016
    Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Elisa BjørgoBiotechnology Centre of Oslo, University of Oslo, P.O. Box 1125, N-0317 Oslo, Norway.
Silje A Solheim
Hilde Abrahamsen
George S Baillie
Kim M Brown
Torunn Berge
Klaus Okkenhaug
Miles D Houslay
Kjetil Taskén
University of Glasgow · GBUniversity of Oslo · NO

Funding

Biotechnology and Biological Sciences Research Council BBS/E/B/0000C236Medical Research Council G0600765
6 · The paper itself

Abstract

Engagement of the T-cell receptor (TCR) in human primary T cells activates a cyclic AMP (cAMP)-protein kinase A (PKA)-Csk inhibitory pathway that prevents full T-cell activation in the absence of a coreceptor stimulus. Here, we demonstrate that stimulation of CD28 leads to recruitment to lipid rafts of a beta-arrestin/phosphodiesterase 4 (PDE4) complex that serves to degrade cAMP locally. Redistribution of the complex from the cytosol depends on Lck and phosphatidylinositol 3-kinase (PI3K) activity. Protein kinase B (PKB) interacts directly with beta-arrestin to form part of the supramolecular complex together with sequestered PDE4. Translocation is mediated by the PKB plextrin homology (PH) domain, thus revealing a new role for PKB as an adaptor coupling PI3K and cAMP signaling. Functionally, PI3K activation and phosphatidylinositol-(3,4,5)-triphosphate (PIP3) production, leading to recruitment of the supramolecular PKB/beta-arrestin/PDE4 complex to the membrane via the PKB PH domain, results in degradation of the TCR-induced cAMP pool located in lipid rafts, thereby allowing full T-cell activation to proceed.

Indexed as

Amino Acid SequenceArrestinsbeta-ArrestinsCD28 AntigensCD3 ComplexCell LineCyclic AMP-Dependent Protein KinasesCyclic Nucleotide Phosphodiesterases, Type 4Enzyme ActivationHumansLymphocyte ActivationLymphocyte Specific Protein Tyrosine Kinase p56(lck)Membrane MicrodomainsMolecular Sequence DataMultiprotein ComplexesPhosphatidylinositol 3-KinasesArrestinsbeta-ArrestinsCD28 AntigensCD3 ComplexCyclic AMP-Dependent Protein KinasesCyclic Nucleotide Phosphodiesterases, Type 4Lymphocyte Specific Protein Tyrosine Kinase p56(lck)Multiprotein ComplexesPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktReceptors, Antigen, T-CellRNA, Small Interfering

Identifiers

PMID20086095
PMCPMC2838077
OpenAlexW2161096310

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.